Your browser doesn't support javascript.
loading
Randomized Phase III Trial Evaluating Subcutaneous Rituximab for the First-Line Treatment of Low-Tumor Burden Follicular Lymphoma: Results of a LYSA Study.
Cartron, Guillaume; Bachy, Emmanuel; Tilly, Hervé; Daguindau, Nicolas; Pica, Gian-Matteo; Bijou, Fontanet; Mounier, Christiane; Clavert, Aline; Damaj, Gandhi Laurent; Slama, Borhane; Casasnovas, Olivier; Houot, Roch; Bouabdallah, Krimo; Sibon, David; Fitoussi, Olivier; Morineau, Nadine; Herbaux, Charles; Gastinne, Thomas; Fornecker, Luc-Matthieu; Haioun, Corinne; Launay, Vincent; Araujo, Carla; Benbrahim, Omar; Sanhes, Laurence; Gressin, Remy; Gonzalez, Hugo; Morschhauser, Franck; Ternant, David; Xerri, Luc; Tarte, Karin; Pranger, Delphine.
Affiliation
  • Cartron G; Department of Hematology, UMR CNRS 5535, University Hospital, Montpellier, France.
  • Bachy E; Department of Hematology, University Hospital, Lyon, France.
  • Tilly H; Department of Hematology, U1245, Henri Becquerel Institute, Rouen, France.
  • Daguindau N; Departement of Hematology, Annecy-Genevois Hospital Centre, Annecy, France.
  • Pica GM; Departement of Hematology, Hospital Centre, Chambery, France.
  • Bijou F; Departement of Hematology, Bergonié Institute, Bordeaux, France.
  • Mounier C; Departement of Hematology, Oncology and Hematology Institute, Sainte-Etienne, France.
  • Clavert A; Departement of Hematology, University Hospital, Angers, France.
  • Damaj GL; Departement of Hematology, University Hospital, Caen, France.
  • Slama B; Departement of Hematology, Hospital Centre, Avignon, France.
  • Casasnovas O; Departement of Hematology, University Hospital, Dijon, France.
  • Houot R; Departement of Hematology, University Hospital, Rennes, France.
  • Bouabdallah K; Departement of Hematology, University Hospital, Bordeaux, France.
  • Sibon D; Departement of Hematology, Necker Hospital, APHP, Paris, France.
  • Fitoussi O; Departement of Hematology, Polyclinic Bordeaux Nord, Bordeaux, France.
  • Morineau N; Departement of Hematology, Hospital Centre, La Roche-sur-Yon, France.
  • Herbaux C; Department of Hematology, UMR CNRS 5535, University Hospital, Montpellier, France.
  • Gastinne T; Departement of Hematology, University Hospital, Nantes, France.
  • Fornecker LM; Departement of Hematology, University Hospital, Strasbourg, France.
  • Haioun C; Departement of Hematology, Lymphoma Malignancies Unit, Henri Mondor Hospital, APHP, Créteil, France.
  • Launay V; Departement of Hematology, Hospital Centre, Saint-Brieuc, France.
  • Araujo C; Departement of Hematology, Hospital Centre, Bayonne, France.
  • Benbrahim O; Departement of Hematology, Hospital Centre, Orléans, France.
  • Sanhes L; Departement of Hematology, Hospital Centre, Perpignan, France.
  • Gressin R; Departement of Hematology, University Hospital, Grenoble, France.
  • Gonzalez H; Departement of Hematology, Hospital Centre, Pontoise, France.
  • Morschhauser F; Department of Hematology, ULR 7365 GRITA, University Hospital, Lille, France.
  • Ternant D; UMR7292, University François-Rabelais, Tours, France.
  • Xerri L; Department of Biopathology, Paoli-Calmettes Institue, Marseille, France.
  • Tarte K; UMR1236, Department of Immunology, Rennes I University, Rennes, France.
  • Pranger D; Department of Haematology, Hospital Centre, Charleroi, Belgium.
J Clin Oncol ; 41(19): 3523-3533, 2023 07 01.
Article de En | MEDLINE | ID: mdl-37071836

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Lymphome folliculaire Type d'étude: Clinical_trials Limites: Humans Langue: En Journal: J Clin Oncol Année: 2023 Type de document: Article Pays d'affiliation: France Pays de publication: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Lymphome folliculaire Type d'étude: Clinical_trials Limites: Humans Langue: En Journal: J Clin Oncol Année: 2023 Type de document: Article Pays d'affiliation: France Pays de publication: États-Unis d'Amérique